CD45 deficiency drives amyloid-β peptide oligomers and neuronal loss in Alzheimer's disease mice
about
Protein phosphatases and Alzheimer's diseaseAlzheimer's disease: new data highlight nonneuronal cell types and the necessity for presymptomatic prevention strategiesInnate immunity in Alzheimer's disease: a complex affairInteractions between inflammation, sex steroids, and Alzheimer's disease risk factorsFerulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic miceIn vivo inhibition of miR-155 significantly alters post-stroke inflammatory responseCR1 and the "vanishing amyloid" hypothesis of Alzheimer's disease.Evaluation of neural damage in Duchenne muscular dystrophy patients.Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer's disease transgenic mouse modelMicroglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaquesIl10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology.Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice.Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-β plaquesThe immunology of neurodegeneration.Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology.Amyloid deposition and advanced age fails to induce Alzheimer's type progression in a double knock-in mouse modelMicroglia in Alzheimer's Disease: It's All About Context.Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer's disease.Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3β signaling pathway.Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation.Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology.α-Synuclein oligomers and clinical implications for Parkinson disease.GFAP expression and social deficits in transgenic mice overexpressing human sAPPα.The role of the innate immune system in Alzheimer's disease and frontotemporal lobar degeneration: an eye on microglia.Mycoplasma hyorhinis markedly degrades β-amyloid peptides in vitro and ex vivo: a novel biological approach for treating Alzheimer's disease?Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where.A matter of life, death and diseases: mitochondria from a proteomic perspective.The neglected role of histamine in Alzheimer's disease.Modulation of inflammation in transgenic models of Alzheimer's diseaseEnvironmental factors in the development and progression of late-onset Alzheimer's disease.Microglial Aβ receptors in Alzheimer's disease.Targeting microglia for the treatment of Alzheimer's disease.Innate immunity in Alzheimer's disease.LISPRO mitigates β-amyloid and associated pathologies in Alzheimer's mice.The protein-tyrosine phosphatase DEP-1 promotes migration and phagocytic activity of microglial cells in part through negative regulation of fyn tyrosine kinase.Exosomes from NSC-34 Cells Transfected with hSOD1-G93A Are Enriched in miR-124 and Drive Alterations in Microglia Phenotype.Efficacy of a therapeutic vaccine using mutated β-amyloid sensitized dendritic cells in Alzheimer's mice.Animal Models of Alzheimer's Disease: Utilization of Transgenic Alzheimer's Disease Models in Studies of Amyloid Beta Clearance.Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice.
P2860
Q24632495-F15FDA22-A4F6-44F0-88FF-75499F634330Q26852851-8A8A3751-9D1D-4CA3-B345-E75CD73A9149Q27006944-508F1DD4-0101-46ED-8347-AA9D0D12BA65Q28394967-31716769-159A-454C-9410-BF7FADAA9AB4Q28486102-B08974C5-EAEC-408F-A605-9EB206E08FE0Q28595988-A3169C0F-D651-4632-9845-584D304FB173Q30421877-3B927456-71D5-4658-B382-D1D178B0B6C8Q33614107-D22B1D24-C7D5-4B2D-A79C-B044A22BA3C8Q34345499-D3240259-9FDE-4711-A2FE-8E5F597272C5Q35030015-80150D63-DDE6-4789-90F2-5E37C1C7B46BQ35155067-8BBB6C7D-2023-4650-81C5-C51EAF0CEBD0Q35758963-E0FB265A-8DF7-4094-A8FD-9FC6C76EBB75Q35838871-920CE7CE-9846-452D-89D0-D7EA190F5EF9Q35840532-839671A8-20EF-47BF-A54E-40838C29879CQ35860997-88B055F6-9DD8-459E-9224-4E0B8D7973BAQ35959633-D0040BB6-1A4F-461A-B74F-C7E94C08EFB5Q36040886-FD70DC0F-A85D-4F89-9BEC-F1EF745562DBQ36072124-6E1D23B9-8BCC-408C-919D-0480C3F8E593Q36156604-9661E50E-90D0-42D4-AA8D-FFBB5822F9ABQ36218830-FCF7AFB1-1808-4B6E-9BD4-2EBFCC95EC99Q36462366-8B38F153-20AA-4B6A-B0D0-D2B1B33DD84BQ36583003-EEDF3D5B-3406-438E-B7DC-255F8D5FEAF7Q36718306-C8E12B96-9E08-44D5-97D7-CD1CAAC47475Q37060402-38B13DB5-0D2C-4326-997E-468BAB1EAB35Q37067641-A72A6069-F2B5-46FE-8284-34DA797D9BA7Q37205567-8A8333B5-CFF2-4E63-9DB0-4605C08BBEC7Q38021993-BAE3611E-3211-497A-8BFC-62348C45A8D7Q38081957-356F5276-39DB-460F-AE03-D4B0AD742782Q38107173-E26235ED-F3CB-4A4E-8F96-50B0BCC8C26EQ38184606-10C85CD1-9064-4113-A041-BB328BEB9647Q38199061-EF227EB6-1F6A-4129-B8F5-F02F8B52AE68Q38242383-1125C5CD-BEF9-4BD7-8E5E-C7B611D10963Q38272915-514F0960-F656-443F-BACA-877F7A615BFCQ38358574-45C7A5AF-CA3A-49C3-BB00-C2FC850BB741Q38724561-07B52773-47C5-4F02-A04A-2FA99FDDC0FAQ38730498-126E34C6-BD82-43BC-B25D-11F9B0521A77Q38752410-FAA77CFF-B24D-4CC0-98FB-649474620125Q39605286-786D7F37-CB45-4945-93F7-B8AE249D9782Q42119910-B69E9957-B17C-4698-8C23-C005C011EDA0Q42134882-DA1D6012-1443-4D0F-946E-B1B1E5131B79
P2860
CD45 deficiency drives amyloid-β peptide oligomers and neuronal loss in Alzheimer's disease mice
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
CD45 deficiency drives amyloid ...... ss in Alzheimer's disease mice
@ast
CD45 deficiency drives amyloid ...... ss in Alzheimer's disease mice
@en
CD45 deficiency drives amyloid ...... ss in Alzheimer's disease mice
@nl
type
label
CD45 deficiency drives amyloid ...... ss in Alzheimer's disease mice
@ast
CD45 deficiency drives amyloid ...... ss in Alzheimer's disease mice
@en
CD45 deficiency drives amyloid ...... ss in Alzheimer's disease mice
@nl
prefLabel
CD45 deficiency drives amyloid ...... ss in Alzheimer's disease mice
@ast
CD45 deficiency drives amyloid ...... ss in Alzheimer's disease mice
@en
CD45 deficiency drives amyloid ...... ss in Alzheimer's disease mice
@nl
P2093
P2860
P1476
CD45 deficiency drives amyloid ...... ss in Alzheimer's disease mice
@en
P2093
Amanda Ruscin
Brian Giunta
Carmelina Gemma
Charles G Glabe
Demian Obregon
Huayan Hou
Jared Ehrhart
Jingji Jin
Kavon Rezai-Zadeh
P2860
P304
P356
10.1523/JNEUROSCI.3268-10.2011
P407
P577
2011-01-01T00:00:00Z